Amendment to Employment Agreement for Dr. Paul Grint with Regulus Therapeutics Inc.
Regulus Therapeutics Inc. has amended its Employment Agreement with Dr. Paul Grint following his promotion to President and CEO. Effective June 1, 2015, Dr. Grint's annual base salary is set at $500,000, and he is eligible for an annual target bonus equal to 50% of his base salary. These changes were approved by the Board of Directors based on the Compensation Committee's recommendation.
Exhibit 10.1
Paul Grint, M.D. Base Salary and Annual Bonus Increase
The Board of Directors (the “Board”) of Regulus Therapeutics Inc. (“Company”), upon the recommendation of the Compensation Committee of the Board, amended the compensation terms of its Employment Agreement with Dr. Grint upon his elevation to President and CEO of the Company. Effective June 1, 2015, Dr. Grint’s annual base salary is $500,000 and he is eligible to receive an annual target bonus of 50% of his annual base salary.
